ALVO · Alvotech
United States · RS rating 86 · As of 2026-10-14
| Price | 5.17 USD |
|---|---|
| 1-day change | -3.9% |
| RS rating (overall / 1M / 3M / 12M) | 86 / 85 / 96 / 19 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 36 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +46.5% |
| Distance from 52-week high | +42.4% |
| Market cap (USD) | $1.1B |